Cargando…
The role of proteomics in depression research
Depression is a severe neuropsychiatric disorder affecting approximately 10% of the world population. Despite this, the molecular mechanisms underlying the disorder are still not understood. Novel technologies such as proteomic-based platforms are beginning to offer new insights into this devastatin...
Autores principales: | Martins-de-Souza, Daniel, Harris, Laura W., Guest, Paul C., Turck, Christoph W., Bahn, Sabine |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2940035/ https://www.ncbi.nlm.nih.gov/pubmed/19997739 http://dx.doi.org/10.1007/s00406-009-0093-2 |
Ejemplares similares
-
Proteomic profiling in schizophrenia: enabling stratification for more effective treatment
por: Guest, Paul C, et al.
Publicado: (2013) -
Identification of proteomic signatures associated with depression and psychotic depression in post-mortem brains from major depression patients
por: Martins-de-Souza, D, et al.
Publicado: (2012) -
Phosphoproteomic differences in major depressive disorder postmortem brains indicate effects on synaptic function
por: Martins-de-Souza, Daniel, et al.
Publicado: (2012) -
Effect of MK-801 and Clozapine on the Proteome of Cultured Human Oligodendrocytes
por: Cassoli, Juliana S., et al.
Publicado: (2016) -
Proteomic Differences in Blood Plasma Associated with Antidepressant Treatment Response
por: Turck, Christoph W., et al.
Publicado: (2017)